Skip to main content

Market Overview

44 Stocks Moving In Thursday's Mid-Day Session



  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares climbed 163.6 percent to $6.3010.
  • Ability Inc. (NASDAQ: ABIL) gained 73.6 percent to $3.7490.
  • AVROBIO, INC. (NASDAQ: AVRO) shares rose 70.3 percent to $32.35. AVROBIO priced its 5.24 million share IPO at $19 per share.
  • Stellar Biotechnologies, Inc. (NASDAQ: SBOT) surged 37.6 percent to $2.27 after announcing encouraging results from a research study focused on the molecular composition of the company's KLH products. The company said the "study results demonstrated highly consistent molecular structure from batch to batch, a key attribute for a biologically sourced protein."
  • TMSR Holding Company Limited (NASDAQ: TMSR) rose 37.5 percent to $5.50.
  • Heron Therapeutics, Inc. (NASDAQ: HRTX) gained 32.1 percent to $40.55 after the company disclosed that HTX-011 for postoperative pain management has received Breakthrough Therapy designation from the FDA.
  • Aptinyx Inc. (NASDAQ: APTX) rose 22.5 percent to $19.59. Aptinyx priced its 6.4 million share IPO at $16 per share.
  • Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) climbed 21.2 percent to $32.02 after announcing pricing of public offering.
  • Barnes & Noble Education Inc (NYSE: BNED) rose 20.3 percent to $8.13 following Q4 results.
  • Xeris Pharmaceuticals Inc (NASDAQ: XERS) climbed 19.1 percent to $17.86. Xeris Pharmaceuticals priced its 5.7 million share IPO at $15 per share.
  • Boxlight Corporation (NASDAQ: BOXL) gained 16.4 percent to $5.98 after the company announced a contract with Clayton County Schools to install mimio classroom solution suite in over 3,200 classrooms.
  • BBVA Banco Francés S.A. (NYSE: BFR) shares rose 14.9 percent to $15.71.
  • Avalara, Inc. (NYSE: AVLR) rose 14.5 percent to $51.55.
  • China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) shares rose 13.1 percent to $4.75.
  • Solid Biosciences Inc. (NASDAQ: SLDB) gained 13 percent to $ 40.30.
  • Darden Restaurants, Inc. (NYSE: DRI) gained 11.8 percent to $104.31 after reporting upbeat earnings for its fourth quarter.
  • Grupo Supervielle S.A. (NYSE: SUPV) shares rose 11.5 percent to $15.27.
  • CASI Pharmaceuticals, Inc. (NASDAQ: CASI) shares gained 10.5 percent to $6.30. The biopharmaceutical said it secured a strategic and long-term manufacturing agreement with China's Yiling Wanzhou for manufacturing of entecavir and cilostazo, two FDA approved products for the treatment of chronic hepatitis B viral and intermittent claudication
  • Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 10.2 percent to $5.65.
  • Mesoblast Limited (NASDAQ: MESO) gained 9.8 percent to $6.08. Mesoblast announced key Day 100 survival outcomes of Phase 3 trial for acute Graft Versus Host Disease
  • Group Inc. (NASDAQ: WEB) rose 9.3 percent to $25.35 after the company agreed to be acquired by an affiliate of Siris Capital Group, LLC for $25 per share in an all-cash deal valued at approximately $2 billion.
  • Kroger Co. (NYSE: KR) rose 9 percent to $28.54 after reporting upbeat results for its first quarter.
  • Grupo Financiero Galicia S.A. (NASDAQ: GGAL) climbed 8.4 percent to $42.03.
  • Loma Negra Compañía Industrial Argentina Sociedad Anónima (NASDAQ: LOMA) rose 7.2 percent to $12.86.
  • ReneSola Ltd (NYSE: SOL) gained 6.6 percent to $2.71. Roth Capital upgraded ReneSola from Sell to Neutral.
  • Voyager Therapeutics Inc (NASDAQ: VYGR) rose 4.5 percent to $22.13. The clinical-stage gene therapy company said the FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation for Voyager's VY-AADC gene therapy treatment for Parkinson's disease in patients with motor fluctuations.

Check out these big penny stock gainers and losers


  • InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares dipped 45.7 percent to $1.83 after reporting pricing of $13.2 million underwritten public offering.
  • Gevo, Inc. (NASDAQ: GEVO) fell 24.7 percent to $9.44 after dropping 35.74 percent on Wednesday.
  • Forward Industries, Inc. (NASDAQ: FORD) shares declined 20.9 percent to $1.74.
  • Naked Brand Group Inc. (NASDAQ: NAKD) shares dipped 20 percent to $6.80.
  • CLPS Incorporation (NASDAQ: CLPS) dropped 19.6 percent to $13.5001 after rising 56.13 percent on Wednesday.
  • Caladrius Biosciences, Inc. (NASDAQ: CLBS) shares dipped 18.3 percent to $7.0550.
  • Veritone, Inc. (NASDAQ: VERI) fell 16.2 percent to $18.11 after reporting a proposed public offering of common stock.
  • YogaWorks, Inc. (NASDAQ: YOGA) dropped 13.7 percent to $1.95.
  • Moleculin Biotech, Inc. (NASDAQ: MBRX) shares slipped 13.4 percent to $1.88. Moleculin reported a $2.3 million registered direct offering priced at-the-market.
  • Alkermes plc (NASDAQ: ALKS) fell 13.4 percent to $44.5001. Morgan Stanley downgraded Alkermes from Equal-Weight to Underweight.
  • Golden Bull Limited (NASDAQ: DNJR) shares tumbled 12.7 percent to $6.1101.
  • Astrotech Corporation (NASDAQ: ASTC) dropped 12.5 percent to $4.36.
  • LiveXLive Media, Inc. (NASDAQ: LIVX) dipped 11.2 percent to $9.260.
  • Steelcase Inc. (NYSE: SCS) fell 9.8 percent to $14.025 following Q1 results.
  • Arbutus Biopharma Corporation (NASDAQ: ABUS) shares fell 9 percent to $6.38.
  • Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT) fell 8.3 percent to $4.08 after rising 37.77 percent on Wednesday.
  • Syntel, Inc. (NASDAQ: SYNT) shares fell 7.3 percent to $31.59. Wells Fargo downgraded Syntel from Market Perform to Underperform.
  • Chegg, Inc. (NYSE: CHGG) dropped 4.7 percent to $28.06. Jefferies downgraded Chegg from Buy to Hold.

Related Articles (ABUS + ABIL)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at